The importance of asymmetric catalysis lies in its ability to produce compounds with high enantiomeric excess (ee), which means a greater proportion of one enantiomer over the other. Many biologically active molecules, including drugs and natural products, are chiral and their biological activity can differ dramatically between enantiomers. Thus, the ability to selectively produce one enantiomer is critical for the development of effective and safe pharmaceuticals.
